Area of research
Hematology · Surgery
Research interest
Research interests include Heparin-Induced Thrombocytopenia and Thrombosis, Platelet Disorders and Treatments, Intramuscular injections and effects, and Venous Thromboembolism Diagnosis and Management.
Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients—Results of the Prospective RADOA Registry
Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation
<i>ABO</i> O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation
The Polygenic and Monogenic Basis of Blood Traits and Diseases
Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
Clinical management, ethics and informed consent related to multi‐gene panel‐based high throughput sequencing testing for platelet disorders: Communication from the SSC of the ISTH
Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitro
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome
Severe Hemorrhage Associated With Oral Anticoagulants
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
The Non-Hemostatic Aspects of Transfused Platelets
Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review